Prenetics Announces Participation in December Investor Conferences
Prenetics Announces Participation in December Investor Conferences
Location: VirtualCHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.
北卡羅來納州夏洛特，2024年12月4日（全球貨幣新聞）-- Prenetics全球有限公司（納斯達克：PRE）（"Prenetics"或"公司"），一家領先的健康科學公司，今天宣佈Prenetics管理團隊成員將參加即將舉行的兩個投資者會議。
iAccess Alpha Virtual Best Ideas Winter Conference 2024
iAccess Alpha虛擬最佳想法冬季大會2024
Date: December 10-11, 2024
日期：2024年12月10-11日
Location: Virtual
地點: 虛擬
Presentation: December 10, 2024 at 10:00am ET
演示：2024年12月10日上午10:00（東部時間）
Webcast:
網絡直播：
Danny Yeung, Chief Executive Officer, will deliver a presentation on December 10, 2024, and will be joined by Stephen Lo, Chief Financial Officer, and David Vanderveen, President of Prenetics Americas, for one-on-one investor meetings to be held on December 11, 2024.
首席執行官Danny Yeung將在2024年12月10日進行演示，屆時將與首席財務官Stephen Lo和Prenetics美洲總裁David Vanderveen一起進行一對一的投資者會議，會議將於2024年12月11日舉行。
13th Annual ROTH Deer Valley Event
第13屆年度ROTH狩獵山谷活動
Date: December 11-13, 2024
日期：2024年12月11日至13日
Location: Park City, UT
位置：猶他州帕克城
David Vanderveen, President of Prenetics Americas, will be hosting one-on-one investor meetings throughout the conference.
Prenetics 美洲總裁大衛·範德維恩將在會議期間主持一對一投資者會議。
Mr. Vanderveen has had a successful 30-year track record in beverage, nutrition, and technology, leading disruptive change at both Nirvana Water Sciences and XS Worldwide as prior CEO.
範德維恩先生在飲料、營養和科技領域擁有30年的成功經驗，曾擔任Nirvana Water Sciences和XS Worldwide的首席執行官，領導了顛覆性的變革。
For more information or to schedule a meeting with management, please contact the Company's investor relations at PRE@mzgroup.us.
如需更多信息或安排與管理層的會議，請聯繫公司的投資者關係處，郵箱地址爲PRE@mzgroup.us。
About Prenetics
關於Prenetics
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics' units synergistically enhances our global impact on health, embodying our commitment to 'enhancing life through science'. To learn more about Prenetics, please visit .
Prenetics（納斯達克:PRE）是一家領先的健康科學公司，致力於推動消費和臨床健康。我們的消費倡議由IM8領導，這是一個新的健康和健身品牌，以及Europa，這是美國最大的體育分銷公司之一。我們的臨床部門由Insighta領導，這是我們的20000萬美元創業公司，專注於多種癌症早期檢測技術。接下來是ACt Genomics，該公司已獲得FDA批准，可以對實體腫瘤進行全面基因組分析，還有CircleDNA，利用NGS提供全面的DNA測試。Prenetics的每個單位協同增強了我們在全球健康方面的影響，體現了我們「通過科學改善生活」的承諾。有關Prenetics的更多信息，請訪問。
Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us
投資者關係聯繫人：
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com
張安琪
投資者關係/企業金融
Prenetics Global Limited
angela.hm.cheung@prenetics.com
譯文內容由第三人軟體翻譯。
